A Bispecific Antibody Targeting RBD and S2 Potently Neutralizes SARS-CoV-2 Omicron and Other Variants of Concern
Mengqi Yuan,Xiangyu Chen,Yanzhi Zhu,Xiaoqing Dong,Yan Liu,Zhaohui Qian,Lilin Ye,Pinghuang Liu
DOI: https://doi.org/10.1128/jvi.00775-22
IF: 6.549
2022-08-03
Journal of Virology
Abstract:The new, highly contagious SARS-CoV-2 Omicron variant caused substantial breakthrough infections and has become the dominant strain in countries across the world. Omicron variants usually bear high mutations in the spike protein and exhibit considerable escape of most potent neutralization monoclonal antibodies and reduced efficacy of current COVID-19 vaccines.
virology
What problem does this paper attempt to address?